TABLE 2.
Drug MIC, presence of β-lactamase, and tetM genes of pre- and post-treatment isolates of N. gonorrhoeae
| Patient | Isolate no. | MIC (mg/liter) of penicillin/β-lactamase | MIC (mg/liter) of tetracycline/tetM | MIC (mg/liter) of: |
|||
|---|---|---|---|---|---|---|---|
| Spectinomycin | Ceftriaxone | Ciprofloxacin | Ofloxacin | ||||
| A | A1 | 0.125/negative | 64/positive | 16 | ≤0.007 | ≤0.007 | 0.03 |
| A2 | 0.25/negative | 4/negative | 8 | ≤0.007 | ≤0.007 | 0.015 | |
| B | B1 | 1/negative | 128/positive | 16 | ≤0.007 | ≤0.007 | 0.03 |
| B2 | 1/negative | 128/positive | 16 | ≤0.007 | 0.125 | 2 | |
| C | C1 | 0.5/negative | 32/positive | 16 | ≤0.007 | ≤0.007 | ≤0.007 |
| C2 | 0.5/negative | 16/positive | 16 | ≤0.007 | ≤0.007 | 0.015 | |
| D | D1 | 8/positive | 32/positive | 16 | ≤0.007 | ≤0.007 | ≤0.007 |
| D2 | 4/positive | 32/positive | 16 | ≤0.007 | ≤0.007 | 0.015 | |
| E | E1 | 0.5/negative | 2/negative | 16 | ≤0.007 | ≤0.007 | 0.015 |
| E2 | 1/negative | 1/negative | 16 | ≤0.007 | ≤0.007 | 0.03 | |
| F | F1 | 0.25/negative | 32/positive | 32 | ≤0.007 | ≤0.007 | 0.015 |
| F2 | 0.25/negative | 32/positive | 16 | ≤0.007 | ≤0.007 | 0.015 | |
| G | G1 | 0.25/negative | 16/positive | 16 | ≤0.007 | ≤0.007 | ≤0.007 |
| G2 | 0.25/negative | 32/positive | 16 | ≤0.007 | ≤0.007 | 0.015 | |